Johannesburg – South Africa on Wednesday approved Pfizer’s coronavirus booster shots for over-18s, as the Omicron variant dominates rising new infections.
The South African Health Products Authority said in a statement that it was authorising a third vaccine dose “in individuals aged 18 years and older, to be administered at least six months after the second dose”.
Severely immuno-compromised children aged between 12 and 17 years can be given a third shot at least 28 days after their second dose, it added.
The statement came hours after BioNTech and Pfizer announced that two doses of their vaccine may not be enough to protect against the highly-mutating Omicron variant which is causing global concern that it can transmit faster than previous strains.
ALSO READ | Pfizer, BioNTech to produce Covid-19 vaccine in South Africa
In preliminary results released on Wednesday, the pharmaceutical companies stressed their jab “is still effective in preventing Covid-19, also against Omicron” after a third shot.
Preliminary results from a small study in South Africa suggested there was up to a 40-fold drop in the ability of the antibodies from the Pfizer-BioNTech vaccine to neutralise Omicron, compared to the earlier Beta variant of coronavirus.
With a cumulative tally of 3 051 222 detected infections and 90,002 deaths, Covid has hit South Africa harder than any other country on the continent.
Follow African Insider on Facebook, Twitter and Instagram
Source: AFP
Picture: Getty Images
For more African news, visit Africaninsider.com
